Trade with Eva: Analytics in action >>

Friday, October 6, 2017

Long trade : ATRS +30% (10/17)

a. 21 Sept. #1, 5; vol. 829K
b. 22 Sept:  #1;  vol. 1.0M;  $3



  



Description

Antares Pharma, Inc. (Antares) is a specialty pharmaceutical company that focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. The Company develops, manufactures and commercializes therapeutic products using its drug delivery systems. Its subcutaneous injection technology platforms include VIBEX disposable pressure-assisted auto injector system suitable for branded and generic injectable drugs in unit dose containers, reusable needle-free spring-action injector devices, and disposable multi-use pen injectors for use with cartridges. The Company makes a reusable, needle-free spring action injection device, ZOMA-Jet or Twin-Jector, which is marketed through its partners for use with human growth hormone (hGH). The Company operates through drug delivery segment, which includes self-administered parenteral pharmaceutical products and technologies.

Key stats and ratios

Q2 (Jun '17)2016
Net profit margin-21.17%-46.61%
Operating margin-20.27%-46.18%
EBITD margin--42.62%
Return on average assets-15.64%-32.26%
Return on average equity-27.89%-43.36%
Employees110

No comments:

Post a Comment